These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35132508)

  • 1. Pulmonary Delivery of Aerosolized Chloroquine and Hydroxychloroquine to Treat COVID-19: In Vitro Experimentation to Human Dosing Predictions.
    Kolli AR; Semren TZ; Bovard D; Majeed S; van der Toorn M; Scheuner S; Guy PA; Kuczaj A; Mazurov A; Frentzel S; Calvino-Martin F; Ivanov NV; O'Mullane J; Peitsch MC; Hoeng J
    AAPS J; 2022 Feb; 24(1):33. PubMed ID: 35132508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translational Modeling of Chloroquine and Hydroxychloroquine Dosimetry in Human Airways for Treating Viral Respiratory Infections.
    Kolli AR; Calvino-Martin F; Hoeng J
    Pharm Res; 2022 Jan; 39(1):57-73. PubMed ID: 35000036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Yao X; Ye F; Zhang M; Cui C; Huang B; Niu P; Liu X; Zhao L; Dong E; Song C; Zhan S; Lu R; Li H; Tan W; Liu D
    Clin Infect Dis; 2020 Jul; 71(15):732-739. PubMed ID: 32150618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxychloroquine as an aerosol might markedly reduce and even prevent severe clinical symptoms after SARS-CoV-2 infection.
    Klimke A; Hefner G; Will B; Voss U
    Med Hypotheses; 2020 Sep; 142():109783. PubMed ID: 32402766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Physiologically-Based Pharmacokinetic (PBPK) Model of Nebulized Hydroxychloroquine for Pulmonary Delivery to COVID-19 Patients.
    Idkaidek N; Hawari F; Dodin Y; Obeidat N
    Drug Res (Stuttg); 2021 May; 71(5):250-256. PubMed ID: 33378773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Strategy to Treat COVID-19 Disease With Targeted Delivery of Inhalable Liposomal Hydroxychloroquine: A Preclinical Pharmacokinetic Study.
    Tai TT; Wu TJ; Wu HD; Tsai YC; Wang HT; Wang AM; Shih SF; Chen YC
    Clin Transl Sci; 2021 Jan; 14(1):132-136. PubMed ID: 33135382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose.
    Doyno C; Sobieraj DM; Baker WL
    Clin Toxicol (Phila); 2021 Jan; 59(1):12-23. PubMed ID: 32960100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What can visual caregivers expect with patients treated for SARS-CoV-2? An analysis of ongoing clinical trials and ocular side effects.
    Fambuena-Muedra I; Jiménez-García M; Hershko S; Altemir-Gómez I; Tobarra-López A
    Eur J Ophthalmol; 2021 Mar; 31(2):291-303. PubMed ID: 33829895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerosol delivery and spatiotemporal tissue distribution of hydroxychloroquine in rat lung.
    Xia W; Kolli AR; Kuczaj AK; Szostak J; Lam S; Toh WW; Purwanti A; Tan WT; Ng R; Phillips B; Peitsch MC; Hoeng J
    Eur J Pharm Sci; 2024 Mar; 194():106693. PubMed ID: 38184016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19).
    Gao J; Hu S
    Biosci Trends; 2020 May; 14(2):156-158. PubMed ID: 32281583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review.
    Hernandez AV; Roman YM; Pasupuleti V; Barboza JJ; White CM
    Ann Intern Med; 2020 Aug; 173(4):287-296. PubMed ID: 32459529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Implications of Chloroquine and Hydroxychloroquine Ototoxicity for COVID-19 Treatment: A Mini-Review.
    Prayuenyong P; Kasbekar AV; Baguley DM
    Front Public Health; 2020; 8():252. PubMed ID: 32574312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
    McEniery CM; Fisk M; Miles K; Kaloyirou F; Hubsch A; Smith J; Wilkinson IB; Cheriyan J
    Trials; 2020 Jul; 21(1):604. PubMed ID: 32616067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population Pharmacokinetics of Hydroxychloroquine in COVID-19 Patients: Implications for Dose Optimization.
    Thémans P; Belkhir L; Dauby N; Yombi JC; De Greef J; Delongie KA; Vandeputte M; Nasreddine R; Wittebole X; Wuillaume F; Lescrainier C; Verlinden V; Kiridis S; Dogné JM; Hamdani J; Wallemacq P; Musuamba FT
    Eur J Drug Metab Pharmacokinet; 2020 Dec; 45(6):703-713. PubMed ID: 32968954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Position statement from the Brazilian Society of Nephrology regarding chloroquine and hydroxychloroquine drug dose adjustment according to renal function.
    Moura-Neto JA; Misael AM; Silva DRD; D'Avila R; Andreoli MCC; Kraychete A; Bastos K; Nascimento MMD
    J Bras Nefrol; 2020 Aug; 42(2 suppl 1):49-50. PubMed ID: 32877501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today's battle against COVID-19?
    Derwand R; Scholz M
    Med Hypotheses; 2020 Sep; 142():109815. PubMed ID: 32408070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing Hydroxychloroquine Dosing for Patients With COVID-19: An Integrative Modeling Approach for Effective Drug Repurposing.
    Garcia-Cremades M; Solans BP; Hughes E; Ernest JP; Wallender E; Aweeka F; Luetkemeyer AF; Savic RM
    Clin Pharmacol Ther; 2020 Aug; 108(2):253-263. PubMed ID: 32285930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine.
    de Barros CM; Almeida CAF; Pereira B; Costa KCM; Pinheiro FA; Maia LDB; Trindade CM; Garcia RCT; Torres LH; Diwan S; Boralli VB
    Pain Physician; 2020 Aug; 23(4S):S351-S366. PubMed ID: 32942793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology.
    White NJ; Watson JA; Hoglund RM; Chan XHS; Cheah PY; Tarning J
    PLoS Med; 2020 Sep; 17(9):e1003252. PubMed ID: 32881895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simulated Assessment of Pharmacokinetically Guided Dosing for Investigational Treatments of Pediatric Patients With Coronavirus Disease 2019.
    Maharaj AR; Wu H; Hornik CP; Balevic SJ; Hornik CD; Smith PB; Gonzalez D; Zimmerman KO; Benjamin DK; Cohen-Wolkowiez M;
    JAMA Pediatr; 2020 Oct; 174(10):e202422. PubMed ID: 32501511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.